Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase 2 Study Of Cisplatin/Pemetrexed With Or Without Axitinib (AG-013736) As First-Line Treatment For Patients With Non-Squamous Non-Small Cell Lung Cancer

NCT00768755 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00768755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00768755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase 2 Study Of Cisplatin/Pemetrexed With Or Without Axitinib (AG-013736) As First-Line Treatment For Patients With Non-Squamous Non-Small Cell Lung Cancer
Lead sponsor
Pfizer
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2009
Completion date
March 31, 2012
Enrollment
180 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small cell lung